Introduction
The lymphoid chemokines CXCL12, CXCL13, CCL19 and CCL21 all regulate migration and compartmentalization of B cells within secondary lymphoid organs under homeostatic as well as activation/inflammatory conditions (Cyster, 2005; Okada and Cyster, 2006) . In lymphoid organs CXCL13 is expressed in B cell follicles and contributes to germinal center (GC) formation by recruiting activated B and follicular helper CD4 + T (T F H) cells expressing its cognate receptor CXCR5 (Victora and Nussenzweig, 2012; Zotos and Tarlinton, 2012; Crotty, 2012 CXCL13 is also associated with lymphoid neogenesis and propagation of humoral responses in non-lymphoid tissue during chronic inflammatory diseases, such as rheumatoid arthritis, Helicobacter pylori gastritis, multiple sclerosis (MS) and primary central nervous system (CNS) lymphoma (Wengner et al., 2007; Finch et al., 2013; Rubenstein et al., 2013; Winter et al., 2010; Fischer et al., 2009) (Krumbholz et al., 2006; Haas et al., 2011; Cepok et al., 2006; Corcione et al., 2004 ) supporting a link between elevated intrathecal CXCL13 and the accumulation of classswitched B mem (Haas et al., 2011) . CXCL13 and B cells in the CSF are also hallmarks of individuals with Lyme neuroborreliosis (LNB) (Kowarik et al., 2012) . In addition, high CXCL13 expression during primary CNS lymphomas, which are predominantly of B cell origin, is associated with inferior outcome as indicated by 10-fold higher CXCL13 levels in the CSF of patients with relapsed primary CNS lymphoma (Rubenstein et al., 2013) 
